Technology for Augmenting Type 1 Diabetes Mellitus Management.
continuous glucose monitoring
continuous subcutaneous infusion
glucagon
insulin
insulin infusion system
type 1 diabetes mellitus
Journal
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
ISSN: 1551-6776
Titre abrégé: J Pediatr Pharmacol Ther
Pays: United States
ID NLM: 101089851
Informations de publication
Date de publication:
Historique:
entrez:
26
4
2019
pubmed:
26
4
2019
medline:
26
4
2019
Statut:
ppublish
Résumé
Type 1 diabetes mellitus has witnessed significant progress in its management over the past several decades. This review highlights technologic advancements in type 1 diabetes management. Continuous glucose monitoring systems are now available at various functionality and cost levels, addressing diverse patient needs, including a recently US Food and Drug Administration (FDA)-approved implantable continuous glucose monitoring system (CGMS). Another dimension to these state-of-the-art technologies is CGMS and insulin pump integration. These integrations have allowed for CGMS-based adjustments to basal insulin delivery rates and suspension of insulin delivery when a low blood glucose event is predicted. This review also includes a brief discussion of upcoming technologies such as patch-based CGMS and insulin-glucagon dual-hormonal delivery.
Identifiants
pubmed: 31019402
doi: 10.5863/1551-6776-24.2.99
pmc: PMC6478356
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
99-106Déclaration de conflit d'intérêts
Disclosure The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts and honoraria.
Références
N Engl J Med. 2008 Oct 2;359(14):1464-76
pubmed: 18779236
Diabetes Care. 2009 Aug;32(8):1378-83
pubmed: 19429875
Diabetes Care. 2009 Nov;32(11):1947-53
pubmed: 19675206
Diabetes Care. 2013 Jul;36(7):2009-14
pubmed: 23378621
J Clin Endocrinol Metab. 2014 May;99(5):1701-11
pubmed: 24483160
N Engl J Med. 2014 Jul 24;371(4):313-325
pubmed: 24931572
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26
pubmed: 25434967
Diabetes Care. 2015 Jun;38(6):971-8
pubmed: 25998289
Lancet Diabetes Endocrinol. 2015 Aug;3(8):595-604
pubmed: 26066705
J Clin Endocrinol Metab. 2016 Jan;101(1):214-23
pubmed: 26523526
Lancet Diabetes Endocrinol. 2016 Mar;4(3):233-243
pubmed: 26850709
Endocr Pract. 2016 Aug;22(8):1008-21
pubmed: 27214060
Endocrine. 2017 Jan;55(1):77-84
pubmed: 27477293
JAMA. 2016 Oct 4;316(13):1407-1408
pubmed: 27629148
Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
Diabetes Ther. 2017 Feb;8(1):55-73
pubmed: 28000140
Diabetes Technol Ther. 2017 Mar;19(3):155-163
pubmed: 28134564
Arch Dis Child. 2017 Jun;102(6):543-549
pubmed: 28137708
Pediatr Diabetes. 2018 Feb;19(1):92-97
pubmed: 28303678
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetes Care. 2018 Apr;41(4):789-796
pubmed: 29444895
Pediatr Diabetes. 2018 Oct;19 Suppl 27:302-325
pubmed: 30039513